Aprea Therapeutics
APRE
APRE
50 hedge funds and large institutions have $31.4M invested in Aprea Therapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 21 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $44.8M → $31.4M (-$13.4M)
62% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 21
65% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 26
Holders
50
Holding in Top 10
1
Calls
$705K
Puts
$723K
Top Buyers
| 1 | +$1.47M | |
| 2 | +$606K | |
| 3 | +$357K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$256K |
| 5 |
JPMorgan Chase & Co
New York
|
+$213K |
Top Sellers
| 1 | -$3.16M | |
| 2 | -$2.21M | |
| 3 | -$1.73M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.71M |
| 5 |
Two Sigma Investments
New York
|
-$1.65M |